roniciclib (BAY 1000394)

DRUG2 trials

Sponsors

Bayer

Conditions

Medical OncologyNeoplasms

Phase 1

Roniciclib Mass Balance Study

CompletedNCT02390154

Start: 2015-04-30End: 2016-06-30Updated: 2016-07-15

Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

CompletedNCT02457351

BayerMedical Oncology

Start: 2015-07-31End: 2016-04-30Updated: 2016-05-23